AlloVir Inc.

NASDAQ: ALVR · Real-Time Price · USD
9.81
0.39 (4.14%)
At close: Mar 18, 2025, 3:59 PM

AlloVir Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 8.38M 8.38M 8.38M 8.38M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 141K 3.78M 3.78M 4.33M 5.28M 1.84M 2.27M 2.56M 2.02M 1.87M 1.48M 1.12M 563K 519K 486K
Gross Profit
n/a n/a 8.24M 4.6M 4.6M 4.05M -5.28M -1.84M -2.27M -2.56M -2.02M -1.87M -1.48M -1.12M -563K -519K -486K
Operating Income
-52.96M -65.44M -80.17M -121.41M -160.94M -181.33M -177.93M -173.92M -171.24M -171.2M -186.56M -189.12M -182.15M -169.82M -139.44M -117.83M -92.33M
Interest Income
4.24M 5.49M 5.47M 5.5M 5.66M 5.74M 5.26M 4.41M 3.05M 1.88M 1.06M 645K 958K 1.31M 1.83M 1.69M 1.38M
Pretax Income
-28.47M -58.77M -100.32M -140.47M -179.66M -190.54M -169.27M -167.07M -166.29M -168.97M -187.36M -190.8M -183.9M -170.96M -139.22M -117.32M -91.37M
Net Income
-28.47M -58.77M -100.2M -140.34M -179.53M -190.42M -168.86M -166.66M -166.03M -168.71M -188.51M -191.95M -184.9M -171.96M -139.22M -117.32M -91.37M
Selling & General & Admin
36.58M 42.92M 34.18M 41.1M 49.92M 51.78M 53.33M 53.47M 50.72M 52.33M 54.51M 54.01M 52.74M 49.08M 43.55M 37.83M 29.11M
Research & Development
6.2M 12.34M 45.25M 79.65M 110.87M 129.41M 123.51M 119.36M 119.43M 117.78M 132.05M 135.11M 129.41M 120.73M 95.89M 80.01M 63.22M
Other Expenses
721K 721K 595K -3.13M -3.64M -4.37M -4.26M -614K -614K -737K -846K -846K -846K n/a n/a n/a n/a
Operating Expenses
43.5M 55.98M 80.02M 117.62M 157.15M 176.82M 172.58M 172.21M 169.53M 169.37M 185.72M 188.27M 181.3M 169.82M 139.44M 117.83M 92.33M
Interest Expense
-1.44M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
33.14M 55.98M 80.17M 121.41M 160.94M 181.33M 177.93M 173.92M 171.24M 171.2M 186.56M 189.12M 182.15M 169.82M 139.44M 117.83M 92.33M
Income Tax Expense
n/a -99.5K -225.5K -311.5K -311.5K -212K -501K -415K -265K -265K 1.16M 1.16M 1.01M 1.01M n/a n/a n/a
Shares Outstanding (Basic)
4.96M 4.96M 4.96M 4.95M 4.93M 4.91M 4.9M 4.07M 4.01M 4M 3.65M 2.77M 2.75M 2.72M 2.71M 2.68M 2.67M
Shares Outstanding (Diluted)
4.96M 4.96M 4.96M 4.95M 4.93M 4.91M 4.9M 4.07M 4.01M 4M 3.65M 2.77M 2.75M 2.72M 2.71M 2.68M 2.67M
EPS (Basic)
-5.72 -11.7 -19.98 -28.12 -37.95 -42.09 -39.56 -42.09 -46.92 -52.67 -64.17 -69.23 -67.16 -62.79 -51.29 -48.07 -40.71
EPS (Diluted)
-5.72 -11.7 -19.98 -28.12 -37.95 -42.09 -39.56 -42.09 -46.92 -52.67 -64.17 -69.23 -67.16 -62.79 -51.29 -48.07 -40.71
EBITDA
-41.59M -54.07M -78.24M -119.57M -160.71M -181.11M -177.76M -173.66M -170.98M -170.48M -185.83M -188.43M -181.51M -169.63M -139.32M -117.75M -92.26M
EBIT
-32.42M -55.26M -79.57M -120.89M -160.94M -181.33M -177.93M -173.92M -171.24M -171.2M -186.56M -189.12M -182.15M -169.82M -139.44M -117.83M -92.33M
Depreciation & Amortization
-99.5K n/a -188.5K -185.5K 411.5K 398K 343K 456K 457K 837K 845K 690K 637K 189K 113K 87K 73K